Advertisement: RSM
Advertisement: TTP
Barr Ellison Solicitors – commercial property
RealVNC mid-banner general
Advertisement: Bradfield Centre mid
Advertisement Cambridge China Centre
Advertisement EY mid banner
RealVNC mid banner careers
ARM Innovation Hub
Mid banner advertisement: BDO
Advertisement: Mogrify
Advertisement: Cambridge Network
Advertisement: Wild Knight Vodka
13 September, 2018 - 13:19 By Kate Sweeney

Global science business acquires Cambridge medical sector specialist

Medical Device Usability, a Cambridge-based human factors services business specialising in medical technology, has been acquired by UL, a US-headquartered global safety science leader.

The deal for the medical devices, drug delivery products and in-vitro diagnostic devices company fortifies Illinois-based UL’s expertise in medical human factors and offers greater access to services by UK and European customers.

Medical Device Usability offers human factors services a portfolio that spans user needs research, user interface design, formative and summative evaluation, and preparation of human factors-related documentation and regulatory submission content. 

The company has deep experience conducting usability tests of medical devices to meet regulatory requirements and helping companies ensure their products will be commercially competitive.

Upayan SenGupta, vice-president and general manager of UL’s Life and Health Sciences business, said: “The application of human factors engineering is critical to effective and safe use of medical devices. 

“Working as one, the combined entity will respond to the growing market need for human factors consulting services across the globe and build on UL’s mission to make the world a safer place while helping companies create and protect their product’s brand value.”

Richard Featherstone, Medical Device Usability’s CEO and founder, added: “We are excited to join forces with UL and, together, offer best-in-class medical human factors services. 

“Our group’s shared reputation for delivering safe and effective medtech services will allow us to significantly accelerate our growth and access to global markets, in addition to providing our customers with a broader range of complementary services and expertise. 

“Clients can rest assured that customer service and technical quality will remain our top priorities and that our newly integrated capabilities will deliver even more value.”

PEM Corporate Finance acted as lead advisor, project managing the sale process and negotiating on behalf of the Medical Device Usability shareholders.

Philip Olagunju, assistant director at PEMCF, said: “It’s been an absolute pleasure advising Richard and Sally Featherstone on the sale of Medical Device Usability. There’s a real strategic fit between the two companies which will create an exciting platform for future growth.”

Legal advice to the vendor was provided by Laurence Evans, partner at Hewitsons LLP.

• PHOTOGRAPH: (left to right) Philip Olagunju of PEM Corporate Finance with Richard and Sally Featherstone of Medical Device Usability.

Newsletter Subscription

Stay informed of the latest news and features